Publications from OUS - The Lipid Clinic
507 publications found
Publications 2024
-
[Patients with severe mental illness do not receive adequate medical assistance in Norway]
Tidsskr Nor Laegeforen, 144 (1)
DOI 10.4045/tidsskr.23.0703, PubMed 38258728 -
Potato Consumption and All-Cause and Cardiovascular Disease Mortality - A Long-Term Follow-Up of a Norwegian Cohort
J Nutr, 154 (7), 2226-2235
DOI 10.1016/j.tjnut.2024.05.011, PubMed 38763265 -
Saturated fatty acids and total and CVD mortality in Norway: a prospective cohort study with up to 45 years of follow-up
Br J Nutr, 132 (4), 1-13 (in press)
DOI 10.1017/S0007114524001351, PubMed 39279644 -
Correction to: Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
Adv Ther, 41 (4), 1765-1769
DOI 10.1007/s12325-023-02739-z, PubMed 38376744 -
Health-related quality of life among women diagnosed with in situ or invasive breast cancer and age-matched controls: a population-based study
J Patient Rep Outcomes, 8 (1), 105
DOI 10.1186/s41687-024-00781-1, PubMed 39298004 -
Inflammatory markers and frailty in home-dwelling elderly, a cross-sectional study
BMC Geriatr, 24 (1), 175
DOI 10.1186/s12877-024-04690-2, PubMed 38373890 -
Association between inflammatory markers, body composition and frailty in home-dwelling elderly: an 8-year follow-up study
Geroscience, 46 (6), 5629-5641
DOI 10.1007/s11357-024-01279-w, PubMed 38981983 -
T cells with increased responsiveness cause obesity in mice without diet intervention
iScience, 27 (4), 109471
DOI 10.1016/j.isci.2024.109471, PubMed 38551005 -
Plasma legumain in familial hypercholesterolemia: associations with statin use and cardiovascular risk markers
Scand J Clin Lab Invest, 84 (1), 24-29
DOI 10.1080/00365513.2024.2309617, PubMed 38319290 -
Real-world impact of transitioning from one lipoprotein(a) assay to another in a clinical setting
Am J Prev Cardiol, 19, 100726
DOI 10.1016/j.ajpc.2024.100726, PubMed 39286651 -
Lipoprotein(a) in children and adolescents with genetically confirmed familial hypercholesterolemia followed up at a specialized lipid clinic
Atheroscler Plus, 57, 13-18
DOI 10.1016/j.athplu.2024.06.002, PubMed 39027312 -
Gastric Bypass vs Diet and Cardiovascular Risk Factors: A Nonrandomized Controlled Trial
JAMA Surg, 159 (9), 971-980
DOI 10.1001/jamasurg.2024.2162, PubMed 38959017 -
Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study
J Diabetes Res, 2024, 6142211
DOI 10.1155/2024/6142211, PubMed 39430801 -
Gene expression profiling in elderly patients with familial hypercholesterolemia with and without coronary heart disease
Atherosclerosis, 392, 117507
DOI 10.1016/j.atherosclerosis.2024.117507, PubMed 38663317 -
Continuous infusion of resolvin D2 in combination with Angiotensin-II show contrary effects on blood pressure and intracardiac artery remodeling
Biochem Biophys Res Commun, 733, 150706
DOI 10.1016/j.bbrc.2024.150706, PubMed 39305571 -
Acute effects of oral mesna administration on the full amino acid profile and 3-methylhistidine: secondary results from the CYLOB dose-finding study
Amino Acids, 56 (1), 39
DOI 10.1007/s00726-024-03398-2, PubMed 38844567 -
Dietary sulfur amino acid restriction in humans with overweight and obesity: a translational randomized controlled trial
J Transl Med, 22 (1), 40
DOI 10.1186/s12967-023-04833-w, PubMed 38195568 -
Dietary sulfur amino acid restriction in humans with overweight and obesity: Evidence of an altered plasma and urine sulfurome, and a novel metabolic signature that correlates with loss of fat mass and adipose tissue gene expression
Redox Biol, 73, 103192
DOI 10.1016/j.redox.2024.103192, PubMed 38776754 -
Dietary intake of micronized avian eggshell membrane in aged mice reduces circulating inflammatory markers, increases microbiota diversity, and attenuates skeletal muscle aging
Front Nutr, 10, 1336477
DOI 10.3389/fnut.2023.1336477, PubMed 38288061 -
How Did Breast Cancer Patients Fare during Different Phases of the COVID-19 Pandemic in Norway Compared to Age-Matched Controls?
Cancers (Basel), 16 (3)
DOI 10.3390/cancers16030602, PubMed 38339359 -
[What a medical certificate should contain]
Tidsskr Nor Laegeforen, 144 (1)
DOI 10.4045/tidsskr.23.0750, PubMed 38258720 -
Effects of Breastfeeding Promotion Intervention and Dietary Treatment in Postpartum Women with Overweight and Obesity: Results from a Randomized Controlled Trial on Weight and Cardiometabolic Risk Factors
J Nutr, 154 (8), 2448-2458
DOI 10.1016/j.tjnut.2024.06.006, PubMed 38901636
Publications 2023
-
Individuals with familial hypercholesterolemia have excess risk of eating disorders: a prospectively matched cohort study
Eur J Prev Cardiol, 30 (4), e13-e15
DOI 10.1093/eurjpc/zwac291, PubMed 36508605 -
Dietary fat quality, plasma atherogenic lipoproteins, and atherosclerotic cardiovascular disease: An overview of the rationale for dietary recommendations for fat intake
Atherosclerosis, 389, 117433
DOI 10.1016/j.atherosclerosis.2023.117433, PubMed 38219649 -
Population-Based Cholesterol Screening as a Primordial Prevention Strategy-Breaking the Cycle of Adverse Lipid Levels That Runs in Families and Tracks Through Life
JAMA Netw Open, 6 (4), e238082
DOI 10.1001/jamanetworkopen.2023.8082, PubMed 37052924 -
Associations between PBMC whole genome transcriptome, muscle strength, muscle mass, and physical performance in healthy home-dwelling older women
Geroscience, 45 (6), 3175-3186
DOI 10.1007/s11357-023-00819-0, PubMed 37204640 -
Correction to: The association of fasting plasma thiol fractions with body fat compartments, biomarker profile, and adipose tissue gene expression
Amino Acids, 55 (4), 547-548
DOI 10.1007/s00726-023-03244-x, PubMed 36795350 -
Plasma cholesterol levels in infancy: a neglected resource
Eur Heart J, 44 (42), 4419-4421
DOI 10.1093/eurheartj/ehad558, PubMed 37632413 -
Sex differences in lipids: A life course approach
Atherosclerosis, 384, 117270
DOI 10.1016/j.atherosclerosis.2023.117270, PubMed 37730457 -
Young women with familial hypercholesterolemia have higher LDL-cholesterol burden than men: Novel data using repeated measurements during 12-years follow-up
Atheroscler Plus, 51, 28-34
DOI 10.1016/j.athplu.2023.01.001, PubMed 36911286 -
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Diabetes Metab, 49 (2), 101418
DOI 10.1016/j.diabet.2022.101418, PubMed 36608816 -
Sex Differences in Familial Hypercholesterolemia
Curr Atheroscler Rep, 25 (11), 861-868
DOI 10.1007/s11883-023-01155-6, PubMed 37815650 -
Dairy fat and cardiovascular disease: good or bad? A lipidologist's view
Eur J Prev Cardiol, 30 (3), 217-218
DOI 10.1093/eurjpc/zwac244, PubMed 36315006 -
Is prediabetes a cardiovascular risk factor in patients with coronary artery disease?
Eur J Prev Cardiol, 30 (14), 1416-1417
DOI 10.1093/eurjpc/zwad097, PubMed 37036914 -
Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency
J Clin Immunol, 43 (6), 1229-1240
DOI 10.1007/s10875-023-01475-x, PubMed 36995502 -
Association between Nordic and Mediterranean diets with lipoprotein phenotype assessed by 1HNMR in children with familial hypercholesterolemia
Atherosclerosis, 373, 38-45
DOI 10.1016/j.atherosclerosis.2023.04.009, PubMed 37137225 -
Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
Eur Heart J, 44 (39), 4157-4173
DOI 10.1093/eurheartj/ehad472, PubMed 37611089 -
Disease progression rate is a strong predictor of ventricular arrhythmias in patients with cardiac laminopathies: a primary prevention cohort study
Europace, 25 (2), 634-642
DOI 10.1093/europace/euac192, PubMed 36352512 -
Associations between dietary intake and glucose tolerance in clinical and metabolomics-based metabotypes
Genes Nutr, 18 (1), 3
DOI 10.1186/s12263-023-00721-6, PubMed 36899329 -
Omega-3 fatty acids and individual variability in plasma triglyceride response: A mini-review
Redox Biol, 63, 102730
DOI 10.1016/j.redox.2023.102730, PubMed 37150150 -
Weight reduction and dietary improvements in a cluster-randomised controlled trial for adults with intellectual disabilities
Food Nutr Res, 67
DOI 10.29219/fnr.v67.9505, PubMed 38187792 -
LDL cholesterol targets rarely achieved in familial hypercholesterolemia patients: A sex and gender-specific analysis
Atherosclerosis, 384, 117117
DOI 10.1016/j.atherosclerosis.2023.03.022, PubMed 37080805 -
[PCSK9 inhibitors on reimbursable prescription: who is eligible?]
Tidsskr Nor Laegeforen, 143 (8)
DOI 10.4045/tidsskr.23.0191, PubMed 37254976 -
Metabolic profiling of pregnancies complicated by preeclampsia: A longitudinal study
Acta Obstet Gynecol Scand, 102 (3), 334-343
DOI 10.1111/aogs.14505, PubMed 36647289 -
Maternal metabolic profiling across body mass index groups: An exploratory longitudinal study
Acta Obstet Gynecol Scand, 103 (3), 540-550
DOI 10.1111/aogs.14750, PubMed 38083835 -
Missense mutation Q384K in the APOB gene affecting the large lipid transfer module of apoB reduces the secretion of apoB-100 in the liver without reducing the secretion of apoB-48 in the intestine
J Clin Lipidol, 17 (6), 800-807
DOI 10.1016/j.jacl.2023.08.009, PubMed 37718180 -
Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: The importance of identifying the underlying cause of hypertriglyceridemia
J Clin Lipidol, 18 (1), e80-e89
DOI 10.1016/j.jacl.2023.11.002, PubMed 37981531 -
Coping After Breast Cancer: Protocol for a Randomized Controlled Trial of Stress Management eHealth Interventions
JMIR Res Protoc, 12, e47195
DOI 10.2196/47195, PubMed 37103493 -
[Correction: High levels of lipoprotein(a) – assessment and treatment]
Tidsskr Nor Laegeforen, 143 (2)
DOI 10.4045/tidsskr.23.0023, PubMed 36718898 -
Protocol for a 20-year follow-up after a randomized controlled trial of a Mediterranean diet in pregnancy: maternal and offspring risk factors for cardiovascular disease
Front Pediatr, 11, 1256815
DOI 10.3389/fped.2023.1256815, PubMed 37920793 -
Low-density lipoprotein particles carrying proinflammatory proteins with altered aggregation pattern detected in COVID-19 patients 3 months after hospitalization
J Infect, 86 (5), 489-492
DOI 10.1016/j.jinf.2023.02.024, PubMed 36822413 -
The association between dairy intake and risk of cardiovascular disease and mortality in patients with stable angina pectoris
Eur J Prev Cardiol, 30 (3), 219-229
DOI 10.1093/eurjpc/zwac217, PubMed 36134600 -
Cysteine-lowering treatment with mesna against obesity: Proof of concept and results from a human phase I, dose-finding study
Diabetes Obes Metab, 25 (11), 3161-3170
DOI 10.1111/dom.15210, PubMed 37435697 -
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia
Cardiovasc Diabetol, 22 (1), 233
DOI 10.1186/s12933-023-01963-9, PubMed 37653496 -
Dietary treatment postpartum in women with obesity reduces weight and prevents weight gain: a randomised controlled trial
BMC Pregnancy Childbirth, 23 (1), 695
DOI 10.1186/s12884-023-05976-w, PubMed 37752466 -
Maternal prenatal cholesterol levels predict offspring weight trajectories during childhood in the Norwegian Mother, Father and Child Cohort Study
BMC Med, 21 (1), 43
DOI 10.1186/s12916-023-02742-9, PubMed 36747215
Publications 2022
-
Maternal lipid levels in early pregnancy as a predictor of childhood lipid levels: a prospective cohort study
BMC Pregnancy Childbirth, 22 (1), 588
DOI 10.1186/s12884-022-04905-7, PubMed 35870883 -
Secular trends in serum lipid profiles in young adults in Norway, 2001-19
Atheroscler Plus, 48, 60-67
DOI 10.1016/j.athplu.2022.03.006, PubMed 36644560 -
Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances
Kardiol Pol, 80 (7-8), 741-749
DOI 10.33963/KP.a2022.0117, PubMed 35521719 -
Differential effects of bariatric surgery and lifestyle interventions on plasma levels of Lp(a) and fatty acids
Lipids Health Dis, 21 (1), 145
DOI 10.1186/s12944-022-01756-1, PubMed 36577984 -
Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial
BMJ, 378, e071245
DOI 10.1136/bmj-2022-071245, PubMed 36215222 -
Glycated Proteins, Glycine, Acetate, and Monounsaturated Fatty Acids May Act as New Biomarkers to Predict the Progression of Type 2 Diabetes: Secondary Analyses of a Randomized Controlled Trial
Nutrients, 14 (23)
DOI 10.3390/nu14235165, PubMed 36501195 -
Simple Nutrient-Based Rules vs. a Nutritionally Rich Plant-Centered Diet in Prediction of Future Coronary Heart Disease and Stroke: Prospective Observational Study in the US
Nutrients, 14 (3)
DOI 10.3390/nu14030469, PubMed 35276828 -
Use of statins and other lipid-modifying agents across pregnancy: A nationwide drug utilization study in Norway in 2005-2018
Atherosclerosis, 368, 25-34
DOI 10.1016/j.atherosclerosis.2022.11.022, PubMed 36522216 -
Gut microbiota is associated with dietary intake and metabolic markers in healthy individuals
Food Nutr Res, 66
DOI 10.29219/fnr.v66.8580, PubMed 35844956 -
Consumption of salmon fishmeal increases hepatic cholesterol content in obese C57BL/6 J mice
Eur J Nutr, 61 (8), 4027-4043
DOI 10.1007/s00394-022-02930-y, PubMed 35788891 -
Postprandial Effects of Salmon Fishmeal and Whey on Metabolic Markers in Serum and Gene Expression in Liver Cells
Nutrients, 14 (8)
DOI 10.3390/nu14081593, PubMed 35458155 -
Resmetirom (MGL-3196) in Patients With Heterozygous Familial Hypercholesterolemia
J Am Coll Cardiol, 79 (12), 1220-1222
DOI 10.1016/j.jacc.2022.01.023, PubMed 35331419 -
The risk of various types of cardiovascular diseases in mutation positive familial hypercholesterolemia; a review
Front Genet, 13, 1072108
DOI 10.3389/fgene.2022.1072108, PubMed 36561318 -
Salmon fish protein supplement increases serum vitamin B12 and selenium concentrations: secondary analysis of a randomised controlled trial
Eur J Nutr, 61 (6), 3085-3093
DOI 10.1007/s00394-022-02857-4, PubMed 35362766 -
Comprehensive lipid and metabolite profiling in healthy adults with low and high consumption of fatty fish: a cross-sectional study - CORRIGENDUM
Br J Nutr, 128 (2), 367-368
DOI 10.1017/S0007114522001519, PubMed 35579033 -
Treatment goals in familial hypercholesterolaemia-time to consider low-density lipoprotein-cholesterol burden
Eur J Prev Cardiol, 29 (17), 2278-2280
DOI 10.1093/eurjpc/zwab228, PubMed 34935933 -
Cascade screening for familial hypercholesterolemia should be organized at a national level
Curr Opin Lipidol, 33 (4), 231-236
DOI 10.1097/MOL.0000000000000832, PubMed 35942821 -
What characterizes event-free elderly FH patients? A comprehensive lipoprotein profiling
Nutr Metab Cardiovasc Dis, 32 (7), 1651-1660
DOI 10.1016/j.numecd.2022.03.028, PubMed 35527125 -
Increased risk of peripheral artery disease in persons with familial hypercholesterolaemia: a prospective registry study
Eur J Prev Cardiol, 28 (18), e11-e13
DOI 10.1093/eurjpc/zwaa024, PubMed 33623989 -
Association of Familial Hypercholesterolemia and Statin Use With Risk of Dementia in Norway
JAMA Netw Open, 5 (4), e227715
DOI 10.1001/jamanetworkopen.2022.7715, PubMed 35438756 -
Statins seldom cause adverse reactions
Tidsskr Nor Laegeforen, 142 (2)
DOI 10.4045/tidsskr.21.0885, PubMed 35107944 -
Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy
Eur Heart J, 43 (45), 4694-4703
DOI 10.1093/eurheartj/ehac485, PubMed 36036653 -
Risk of stroke in genetically verified familial hypercholesterolemia: A prospective matched cohort study
Atherosclerosis, 358, 34-40
DOI 10.1016/j.atherosclerosis.2022.08.015, PubMed 36084445 -
Why we can probably trust public policy dietary guidelines for prevention
Eur J Prev Cardiol, 29 (6), e209-e210
DOI 10.1093/eurjpc/zwaa008, PubMed 33624034 -
High levels of lipoprotein(a) - assessment and treatment
Tidsskr Nor Laegeforen, 142 (1)
DOI 10.4045/tidsskr.21.0800, PubMed 36655975 -
Replacing saturated fatty acids with polyunsaturated fatty acids increases the abundance of Lachnospiraceae and is associated with reduced total cholesterol levels-a randomized controlled trial in healthy individuals
Lipids Health Dis, 21 (1), 92
DOI 10.1186/s12944-022-01702-1, PubMed 36163070 -
A Three-Day Intervention With Granola Containing Cereal Beta-Glucan Improves Glycemic Response and Changes the Gut Microbiota in Healthy Individuals: A Crossover Study
Front Nutr, 9, 796362
DOI 10.3389/fnut.2022.796362, PubMed 35578615 -
Editorial: Genetics of familial hypercholesterolemia: New insight-Volume II
Front Genet, 13, 1041342
DOI 10.3389/fgene.2022.1041342, PubMed 36313446 -
Effects of dietary and exercise treatments on HDL subclasses in lactating women with overweight and obesity: a secondary analysis of a randomised controlled trial
Br J Nutr, 128 (11), 2105-2114
DOI 10.1017/S0007114522000241, PubMed 35067237 -
Circulating Lipoproteins in Subjects with Morbid Obesity Undergoing Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy
Nutrients, 14 (12)
DOI 10.3390/nu14122381, PubMed 35745111 -
Reply to Paredes et al. Comment on "Aaseth et al. Circulating Lipoproteins in Subjects with Morbid Obesity Undergoing Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy. Nutrients 2022, 14, 2381"
Nutrients, 15 (1)
DOI 10.3390/nu15010053, PubMed 36615711
Publications 2021
-
Risk of Recurrent Coronary Events in Patients With Familial Hypercholesterolemia; A 10-Years Prospective Study
Front Pharmacol, 11, 560958
DOI 10.3389/fphar.2020.560958, PubMed 33737874 -
The Long-term Effect of Different Exercise Intensities on High-Density Lipoprotein Cholesterol in Older Men and Women Using the Per Protocol Approach: The Generation 100 Study
Mayo Clin Proc Innov Qual Outcomes, 5 (5), 859-871
DOI 10.1016/j.mayocpiqo.2021.07.002, PubMed 34585083 -
Children with familial hypercholesterolemia display changes in LDL and HDL function: A cross-sectional study
J Intern Med, 290 (5), 1083-1097
DOI 10.1111/joim.13383, PubMed 34506681 -
Long term follow-up of children with familial hypercholesterolemia and relatively normal LDL-cholesterol at diagnosis
J Clin Lipidol, 15 (2), 375-378
DOI 10.1016/j.jacl.2021.01.007, PubMed 33608220 -
Loss of statin treatment years during pregnancy and breastfeeding periods in women with familial hypercholesterolemia
Atherosclerosis, 335, 8-15
DOI 10.1016/j.atherosclerosis.2021.09.003, PubMed 34520888 -
Thirty percent of children and young adults with familial hypercholesterolemia treated with statins have adherence issues
Am J Prev Cardiol, 6, 100180
DOI 10.1016/j.ajpc.2021.100180, PubMed 34327501 -
Left Ventricular Dysfunction in Arrhythmogenic Cardiomyopathy: Association With Exercise Exposure, Genetic Basis, and Prognosis
J Am Heart Assoc, 10 (8), e018680
DOI 10.1161/JAHA.120.018680, PubMed 33821670 -
Excess Aortic Pathology Risk in Patients with Genetically Verified Familial Hypercholesterolaemia: A Prospective Norwegian Registry Study
Eur J Vasc Endovasc Surg, 61 (4), 712-713
DOI 10.1016/j.ejvs.2020.12.019, PubMed 33485759 -
Comparison of methods to identify individuals with obesity at increased risk of functional impairment among a population of home-dwelling older adults
Br J Nutr, 128 (6), 1064-1071
DOI 10.1017/S0007114521004128, PubMed 34749837 -
Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registry
Ann Med, 53 (1), 485-494
DOI 10.1080/07853890.2021.1893897, PubMed 33818226 -
[What about reactions after COVID-19 infection or vaccination?]
Tidsskr Nor Laegeforen, 141
DOI 10.4045/tidsskr.21.0582, PubMed 34505487 -
[Retterstøl and colleagues respond]
Tidsskr Nor Laegeforen, 141 (4)
DOI 10.4045/tidsskr.21.0122, PubMed 33685109 -
[Lower treatment goals for LDL cholesterol should be introduced]
Tidsskr Nor Laegeforen, 141 (2)
DOI 10.4045/tidsskr.20.0761, PubMed 33528123 -
[Correction: Lower treatment goals for LDL cholesterol should be introduced]
Tidsskr Nor Laegeforen, 141 (4)
DOI 10.4045/tidsskr.21.0096, PubMed 33685112 -
Dietary intake and lipid levels in Norwegian and Spanish children with familial hypercholesterolemia
Nutr Metab Cardiovasc Dis, 31 (4), 1299-1307
DOI 10.1016/j.numecd.2020.12.002, PubMed 33549456 -
LongITools: Dynamic longitudinal exposome trajectories in cardiovascular and metabolic noncommunicable diseases
Environ Epidemiol, 6 (1), e184
DOI 10.1097/EE9.0000000000000184, PubMed 35169663 -
Sulfur amino acid restriction, energy metabolism and obesity: a study protocol of an 8-week randomized controlled dietary intervention with whole foods and amino acid supplements
J Transl Med, 19 (1), 153
DOI 10.1186/s12967-021-02824-3, PubMed 33858441 -
Gender differences in nutrition literacy levels among university students and employees: a descriptive study
J Nutr Sci, 10, e56
DOI 10.1017/jns.2021.47, PubMed 34367630 -
The homeoviscous adaptation to dietary lipids (HADL) model explains controversies over saturated fat, cholesterol, and cardiovascular disease risk
Am J Clin Nutr, 113 (2), 277-289
DOI 10.1093/ajcn/nqaa322, PubMed 33471045 -
Novel associations between parental and newborn cord blood metabolic profiles in the Norwegian Mother, Father and Child Cohort Study
BMC Med, 19 (1), 91
DOI 10.1186/s12916-021-01959-w, PubMed 33849542 -
Cholesterol at ages 6, 12 and 24 months: Tracking and associations with diet and maternal cholesterol in the Infant Cholesterol Study
Atherosclerosis, 326, 11-16
DOI 10.1016/j.atherosclerosis.2021.04.017, PubMed 33990045
Publications 2020
-
Prevalence of genetically verified familial hypercholesterolemia among young (<45 years) Norwegian patients hospitalized with acute myocardial infarction
J Clin Lipidol, 14 (3), 339-345
DOI 10.1016/j.jacl.2020.04.002, PubMed 32418822 -
Corrigendum to "Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia" J Clin Lipidol 11 (2017) 1338-1346
J Clin Lipidol, 14 (5), 742
DOI 10.1016/j.jacl.2020.09.010, PubMed 33138962 -
Beneficial effect on serum cholesterol levels, but not glycaemic regulation, after replacing SFA with PUFA for 3 d: a randomised crossover trial
Br J Nutr, 125 (8), 915-925
DOI 10.1017/S0007114520003402, PubMed 32873354 -
Subjects with familial hypercholesterolemia have lower aortic valve area and higher levels of inflammatory biomarkers
J Clin Lipidol, 15 (1), 134-141
DOI 10.1016/j.jacl.2020.12.006, PubMed 33358307 -
Anti-inflammatory effects of non-statin low-density lipoprotein cholesterol-lowering drugs: an unused potential?
Scand Cardiovasc J, 54 (5), 274-279
DOI 10.1080/14017431.2020.1775878, PubMed 32500743 -
Lipoprotein retention in the vascular wall - a potential therapeutic target?
Tidsskr. Nor. Laegeforen., 140 (10), 987-989 -
Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
Cardiovasc Drugs Ther, 34 (4), 515-523
DOI 10.1007/s10557-020-06984-0, PubMed 32363493 -
Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME®
Diab Vasc Dis Res, 17 (6), 1479164120975256
DOI 10.1177/1479164120975256, PubMed 33307785 -
Nutritional challenges in children and adolescents with Down syndrome
Lancet Child Adolesc Health, 4 (6), 455-464
DOI 10.1016/S2352-4642(19)30400-6, PubMed 32450124 -
Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings
J Lipid Res, 61 (8), 1142-1149
DOI 10.1194/jlr.S120000720, PubMed 32482717 -
Effects of dietary methionine and cysteine restriction on plasma biomarkers, serum fibroblast growth factor 21, and adipose tissue gene expression in women with overweight or obesity: a double-blind randomized controlled pilot study
J Transl Med, 18 (1), 122
DOI 10.1186/s12967-020-02288-x, PubMed 32160926 -
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action
JAMA Cardiol, 5 (2), 217-229
DOI 10.1001/jamacardio.2019.5173, PubMed 31895433 -
Factors influencing the opportunities of supporting staff to promote a healthy diet in adults with intellectual disabilities
J Appl Res Intellect Disabil, 34 (3), 733-741
DOI 10.1111/jar.12846, PubMed 33274594 -
Familial hypercholesterolaemia: history, diagnosis, screening, management and challenges
Heart, 106 (24), 1940-1946
DOI 10.1136/heartjnl-2019-316276, PubMed 32933999 -
Evaluating the use of the heart age tool in community pharmacies: a 4-week cluster-randomized controlled trial
Eur J Public Health, 30 (6), 1139-1145
DOI 10.1093/eurpub/ckaa048, PubMed 32206810 -
2.5-fold increased risk of recurrent acute myocardial infarction with familial hypercholesterolemia
Atherosclerosis, 319, 28-34
DOI 10.1016/j.atherosclerosis.2020.12.019, PubMed 33465659 -
Genetic testing is essential for initiating statin therapy in children with familial hypercholesterolemia: Examples from Scandinavia
Atherosclerosis, 316, 48-52
DOI 10.1016/j.atherosclerosis.2020.11.027, PubMed 33302044 -
Fatty acid profile and estimated desaturase activities in whole blood are associated with metabolic health
Lipids Health Dis, 19 (1), 102
DOI 10.1186/s12944-020-01282-y, PubMed 32438926 -
A comprehensive metabolic profiling of the metabolically healthy obesity phenotype
Lipids Health Dis, 19 (1), 90
DOI 10.1186/s12944-020-01273-z, PubMed 32386512
Publications 2019
-
Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
Adv Ther, 36 (7), 1786-1811
DOI 10.1007/s12325-019-00985-8, PubMed 31102204 -
LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia
J Clin Lipidol, 13 (2), 279-286
DOI 10.1016/j.jacl.2019.01.010, PubMed 30910667 -
Serum Omega-6 Fatty Acids and Immunology-Related Gene Expression in Peripheral Blood Mononuclear Cells: A Cross-Sectional Analysis in Healthy Children
Mol Nutr Food Res, 63 (7), e1800990
DOI 10.1002/mnfr.201800990, PubMed 30702198 -
Long-Term Efficacy and Safety of Evolocumab in Patients With Hypercholesterolemia
J Am Coll Cardiol, 74 (17), 2132-2146
DOI 10.1016/j.jacc.2019.08.1024, PubMed 31648705 -
Lower risk of smoking-related cancer in individuals with familial hypercholesterolemia compared with controls: a prospective matched cohort study
Sci Rep, 9 (1), 19273
DOI 10.1038/s41598-019-55682-x, PubMed 31848411 -
Impaired HDL Function Amplifies Systemic Inflammation in Common Variable Immunodeficiency
Sci Rep, 9 (1), 9427
DOI 10.1038/s41598-019-45861-1, PubMed 31263122 -
Association of Low-Density Lipoprotein Cholesterol With Risk of Aortic Valve Stenosis in Familial Hypercholesterolemia
JAMA Cardiol, 4 (11), 1156-1159
DOI 10.1001/jamacardio.2019.3903, PubMed 31617858 -
Efficacy and Safety of Alirocumab 300 mg Every 4 Weeks in Individuals With Type 2 Diabetes on Maximally Tolerated Statin
J Clin Endocrinol Metab, 104 (11), 5253-5262
DOI 10.1210/jc.2018-02703, PubMed 31166599 -
Lipoprotein(a) concentration is associated with plasma arachidonic acid in subjects with familial hypercholesterolaemia
Br J Nutr, 122 (7), 790-799
DOI 10.1017/S0007114519001600, PubMed 31262370 -
Profiling of immune-related gene expression in children with familial hypercholesterolaemia
J Intern Med, 287 (3), 310-321
DOI 10.1111/joim.13001, PubMed 31631426 -
Community pharmacies offer a potential high-yield and convenient arena for total cholesterol and CVD risk screening
Eur J Public Health, 29 (1), 17-23
DOI 10.1093/eurpub/cky190, PubMed 30239673 -
Milk and Dairy Product Consumption and Inflammatory Biomarkers: An Updated Systematic Review of Randomized Clinical Trials
Adv Nutr, 10 (suppl_2), S239-S250
DOI 10.1093/advances/nmy072, PubMed 31089732 -
Economic evaluation of lipid lowering with PCSK9 inhibitors in patients with familial hypercholesterolemia: Methodological aspects
Atherosclerosis, 287, 140-146
DOI 10.1016/j.atherosclerosis.2019.06.900, PubMed 31280039 -
Infant cholesterol and glycated haemoglobin concentrations vary widely-Associations with breastfeeding, infant diet and maternal biomarkers
Acta Paediatr, 109 (1), 115-121
DOI 10.1111/apa.14936, PubMed 31299108 -
Postprandial changes in gene expression of cholesterol influx and efflux mediators after intake of SFA compared with n-6 PUFA in subjects with and without familial hypercholesterolaemia: secondary outcomes of a randomised controlled trial
J Nutr Sci, 8, e27
DOI 10.1017/jns.2019.25, PubMed 31448116
Publications 2018
-
Individualized low-density lipoprotein cholesterol reduction with alirocumab titration strategy in heterozygous familial hypercholesterolemia: Results from an open-label extension of the ODYSSEY LONG TERM trial
J Clin Lipidol, 13 (1), 138-147
DOI 10.1016/j.jacl.2018.11.007, PubMed 30591415 -
Long-term safety and efficacy of alirocumab in patients with heterozygous familial hypercholesterolemia: An open-label extension of the ODYSSEY program
Atherosclerosis, 278, 307-314
DOI 10.1016/j.atherosclerosis.2018.08.036, PubMed 30293878 -
Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT study
J Clin Lipidol, 12 (5), 1199-1207
DOI 10.1016/j.jacl.2018.05.007, PubMed 30318065 -
Sex differences in cholesterol levels from birth to 19 years of age may lead to increased cholesterol burden in females with FH
J Clin Lipidol, 12 (3), 748-755.e2
DOI 10.1016/j.jacl.2018.02.021, PubMed 29609857 -
The right to a health promoting diet for people with intellectual disabilities
Tidsskr. Nor. Laegeforen., 138 (2), 122-123 -
Alirocumab dosing patterns during 40 months of open-label treatment in patients with heterozygous familial hypercholesterolemia
J Clin Lipidol, 12 (6), 1463-1470
DOI 10.1016/j.jacl.2018.08.011, PubMed 30287210 -
Risk of Ischemic Stroke and Total Cerebrovascular Disease in Familial Hypercholesterolemia: A Register Study From Norway
Stroke, 50 (1), 172-174
DOI 10.1161/STROKEAHA.118.023456, PubMed 30580708 -
Securing rights and nutritional health for persons with intellectual disabilities - a pressing challenge
Food Nutr Res, 62
DOI 10.29219/fnr.v62.1268, PubMed 29899685 -
Are PCSK9 Inhibitors Cost Effective?
Pharmacoeconomics, 36 (9), 1031-1041
DOI 10.1007/s40273-018-0671-0, PubMed 29777433 -
Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)"
Circulation, 137 (6), 641-642
DOI 10.1161/CIRCULATIONAHA.117.031676, PubMed 29431667 -
Some children with a familial hypercholesterolemia mutation may exhibit persistent low LDL levels
J Clin Lipidol, 12 (5), 1327-1328
DOI 10.1016/j.jacl.2018.06.012, PubMed 30033003 -
Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials)
Am J Cardiol, 121 (8), 940-948
DOI 10.1016/j.amjcard.2017.12.040, PubMed 29472008 -
Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia
Heart, 104 (19), 1600-1607
DOI 10.1136/heartjnl-2017-312706, PubMed 29622598 -
The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions
Heart Fail Rev, 23 (3), 303-323
DOI 10.1007/s10741-018-9685-0, PubMed 29516230 -
Response to the editor
Heart Fail Rev (in press)
DOI 10.1007/s10741-018-9723-y, PubMed 29968222 -
Author's response to: letter to the editor
Heart Fail Rev, 23 (5), 819
DOI 10.1007/s10741-018-9728-6, PubMed 30043131 -
Effect of low carbohydrate high fat diet on LDL cholesterol and gene expression in normal-weight, young adults: A randomized controlled study
Atherosclerosis, 279, 52-61
DOI 10.1016/j.atherosclerosis.2018.10.013, PubMed 30408717 -
Evaluation of a short Food Frequency Questionnaire to assess cardiovascular disease-related diet and lifestyle factors
Food Nutr Res, 62
DOI 10.29219/fnr.v62.1370, PubMed 29720928 -
A randomized controlled trial in Norwegian pharmacies on effects of risk alert and advice in people with elevated cardiovascular risk
Prev Med Rep, 12, 79-86
DOI 10.1016/j.pmedr.2018.08.004, PubMed 30191097 -
Familial hypercholesterolemia and young patients' thoughts on own condition and treatment
Patient Educ Couns, 102 (5), 1005-1012
DOI 10.1016/j.pec.2018.12.025, PubMed 30606641 -
Delayed postprandial TAG peak after intake of SFA compared with PUFA in subjects with and without familial hypercholesterolaemia: a randomised controlled trial
Br J Nutr, 120 (5), 597
DOI 10.1017/S0007114518001769, PubMed 30047345
Publications 2017
-
Recommended Nordic diet and risk markers for cardiovascular disease
Tidsskr Nor Laegeforen, 137 (10), 721-726
DOI 10.4045/tidsskr.16.0243, PubMed 28551971 -
A physically fit woman in her thirties with exertional dyspnoea
Tidsskr Nor Laegeforen, 137 (6), 456-458
DOI 10.4045/tidsskr.16.0538, PubMed 28332800 -
Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of 302 children in Norway
J Clin Lipidol, 12 (2), 375-382
DOI 10.1016/j.jacl.2017.11.009, PubMed 29310990 -
Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)
Circulation, 136 (4), 359-366
DOI 10.1161/CIRCULATIONAHA.116.025158, PubMed 28592434 -
Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study
Atherosclerosis, 266, 48-57
DOI 10.1016/j.atherosclerosis.2017.09.021, PubMed 28963918 -
Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia
J Clin Lipidol, 11 (6), 1338-1346.e7
DOI 10.1016/j.jacl.2017.08.016, PubMed 28964736 -
Gene expression is differentially regulated in skeletal muscle and circulating immune cells in response to an acute bout of high-load strength exercise
Genes Nutr, 12, 8
DOI 10.1186/s12263-017-0556-4, PubMed 28270867 -
Consumption of protein-enriched milk has minor effects on inflammation in older adults-A 12-week double-blind randomized controlled trial
Mech Ageing Dev, 162, 1-8
DOI 10.1016/j.mad.2017.01.011, PubMed 28163108 -
Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia
J Clin Lipidol, 12 (2), 390-396.e8
DOI 10.1016/j.jacl.2017.12.008, PubMed 29396260 -
Increased risk of heart failure and atrial fibrillation in heterozygous familial hypercholesterolemia
Atherosclerosis, 266, 69-73
DOI 10.1016/j.atherosclerosis.2017.09.027, PubMed 28992466 -
Bariatric surgery reduces fasting total fatty acids and increases n-3 polyunsaturated fatty acids in morbidly obese individuals
Scand J Clin Lab Invest, 77 (8), 628-633
DOI 10.1080/00365513.2017.1393691, PubMed 29069988 -
Long-term Low-Density Lipoprotein Cholesterol-Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia: Results Up to 4 Years From the Open-Label OSLER-1 Extension Study
JAMA Cardiol, 2 (6), 598-607
DOI 10.1001/jamacardio.2017.0747, PubMed 28291870 -
[Not Available]
Tidsskr Nor Laegeforen, 137 (3), 225
DOI 10.4045/tidsskr.16.1015, PubMed 28181769 -
[Misleading about diet in a new national guideline for the prevention of cardiovascular disease]
Tidsskr Nor Laegeforen, 137 (20)
DOI 10.4045/tidsskr.17.0834, PubMed 29094560 -
Misleading about diet in new national guideline for prevention of cardiovascular disease
Tidsskr. Nor. Laegeforen., 137 (20), 1584-1586 -
More harm than benefit - how much should the patients know?
Tidsskr. Nor. Laegeforen., 137 (9), 598 -
Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics
Lipids Health Dis, 16 (1), 115
DOI 10.1186/s12944-017-0511-9, PubMed 28606150 -
Saturated fat -a never ending story?
Food Nutr Res, 61 (1), 1377572
DOI 10.1080/16546628.2017.1377572, PubMed 29056889 -
Does dietary fat affect inflammatory markers in overweight and obese individuals?-a review of randomized controlled trials from 2010 to 2016
Genes Nutr, 12, 26
DOI 10.1186/s12263-017-0580-4, PubMed 29043006
Publications 2016
-
Comments on Moderate Alcohol Consumption and Mortality
J Stud Alcohol Drugs, 77 (5), 834-6
DOI 10.15288/jsad.2016.77.834, PubMed 27588543 -
Data on circulating leukocyte subpopulations and inflammatory proteins in children with familial hypercholesterolemia and healthy children
Data Brief, 10, 587-592
DOI 10.1016/j.dib.2016.12.042, PubMed 28070551 -
Altered leukocyte distribution under hypercholesterolemia: A cross-sectional study in children with familial hypercholesterolemia
Atherosclerosis, 256, 67-74
DOI 10.1016/j.atherosclerosis.2016.11.031, PubMed 28024183 -
LDL cholesterol in early pregnancy and offspring cardiovascular disease risk factors
J Clin Lipidol, 10 (6), 1369-1378.e7
DOI 10.1016/j.jacl.2016.08.016, PubMed 27919354 -
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration
Atheroscler Suppl, 22, 1-32
DOI 10.1016/j.atherosclerosissup.2016.10.001, PubMed 27939304 -
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro
Diabetologia, 59 (10), 2134-44
DOI 10.1007/s00125-016-4036-y, PubMed 27421726 -
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholesterolemia
J Clin Lipidol, 11 (1), 195-203.e4
DOI 10.1016/j.jacl.2016.12.004, PubMed 28391886 -
Replacing statins with PCSK9-inhibitors and delaying treatment until 18 years of age in patients with familial hypercholesterolaemia is not a good idea
Eur Heart J, 37 (17), 1357-9
DOI 10.1093/eurheartj/ehw098, PubMed 27026748 -
A 3-year study of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia
J Clin Lipidol, 10 (5), 1153-1162.e3
DOI 10.1016/j.jacl.2016.05.010, PubMed 27678432 -
Simultaneous Reduction in Both HbA1c and Body Weight with Canagliflozin Versus Glimepiride in Patients with Type 2 Diabetes on Metformin
Diabetes Ther, 7 (2), 269-78
DOI 10.1007/s13300-016-0163-1, PubMed 26984361 -
Health-related quality of life, sense of coherence and leisure-time physical activity in women after an acute myocardial infarction
J Clin Nurs, 26 (7-8), 975-982
DOI 10.1111/jocn.13411, PubMed 27239746 -
Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials
Br J Nutr, 115 (3), 466-79
DOI 10.1017/S0007114515004699, PubMed 26768850 -
Low-carbohydrate diets increase LDL-cholesterol, and thereby indicate increased risk of CVD
Br J Nutr, 115 (12), 2264-6
DOI 10.1017/S0007114516001343, PubMed 27376624 -
Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013
Eur J Prev Cardiol, 24 (2), 137-144
DOI 10.1177/2047487316676135, PubMed 27794106 -
A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries
Curr Opin Lipidol, 27 (4), 388-97
DOI 10.1097/MOL.0000000000000300, PubMed 27070076 -
Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study
Eur J Prev Cardiol, 23 (18), 1962-1969
DOI 10.1177/2047487316666371, PubMed 27558979 -
The prevalence of metabolic risk factors of atherosclerotic cardiovascular disease in Williams syndrome, Prader-Willi syndrome, and Down syndrome
J. Intellect. Dev. Dis., 41 (3), 187-196
DOI 10.3109/13668250.2016.1167845 -
Bioavailability of n-3 fatty acids from n-3-enriched foods and fish oil with different oxidative quality in healthy human subjects: a randomised single-meal cross-over study
J Nutr Sci, 5, e43
DOI 10.1017/jns.2016.34, PubMed 28620470 -
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia
J Clin Lipidol, 10 (4), 816-823
DOI 10.1016/j.jacl.2016.02.015, PubMed 27578112 -
A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I
Atherosclerosis, 254, 254-262
DOI 10.1016/j.atherosclerosis.2016.08.043, PubMed 27639753 -
Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia
Atherosclerosis, 252, 21-27
DOI 10.1016/j.atherosclerosis.2016.07.913, PubMed 27494447
Publications 2015
-
Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk
J Pediatr, 167 (2), 338-43.e5
DOI 10.1016/j.jpeds.2015.05.006, PubMed 26059337 -
Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study
J Clin Lipidol, 9 (6), 741-750
DOI 10.1016/j.jacl.2015.07.011, PubMed 26687694 -
Effects of Exercise on Gene Expression of Inflammatory Markers in Human Peripheral Blood Cells: A Systematic Review
Curr Cardiovasc Risk Rep, 9 (7), 34
DOI 10.1007/s12170-015-0463-4, PubMed 26005511 -
Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study
Lancet, 385 (9983), 2153-61
DOI 10.1016/S0140-6736(14)62115-2, PubMed 25743173 -
ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia
Eur Heart J, 36 (43), 2996-3003
DOI 10.1093/eurheartj/ehv370, PubMed 26330422 -
Vascular risk factors, vascular disease, lipids and lipid targets in patients with familial dysbetalipoproteinemia: a European cross-sectional study
Atherosclerosis, 240 (1), 90-7
DOI 10.1016/j.atherosclerosis.2015.02.046, PubMed 25768710 -
Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death
Eur Heart J, 37 (17), 1398-405
DOI 10.1093/eurheartj/ehv602, PubMed 26586781 -
Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhood
J Clin Lipidol, 9 (6), 778-785
DOI 10.1016/j.jacl.2015.08.008, PubMed 26687698 -
Evolocumab (AMG 145) for primary hypercholesterolemia
Expert Rev Cardiovasc Ther, 13 (5), 477-88
DOI 10.1586/14779072.2015.1030395, PubMed 25824308 -
[Increased mortality in familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 135 (11), 1024-5
DOI 10.4045/tidsskr.15.0244, PubMed 26080775 -
Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia
Atherosclerosis, 243 (1), 155-60
DOI 10.1016/j.atherosclerosis.2015.09.014, PubMed 26386212 -
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events
N Engl J Med, 372 (16), 1489-99
DOI 10.1056/NEJMoa1501031, PubMed 25773378 -
Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION)
Diabetes Obes Metab, 17 (7), 630-8
DOI 10.1111/dom.12461, PubMed 25761977 -
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
Eur Heart J, 36 (36), 2425-37
DOI 10.1093/eurheartj/ehv157, PubMed 26009596
Publications 2014
-
Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene
Atherosclerosis, 234 (1), 30-3
DOI 10.1016/j.atherosclerosis.2014.02.005, PubMed 24589565 -
Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment
Atherosclerosis, 233 (2), 561-567
DOI 10.1016/j.atherosclerosis.2014.01.022, PubMed 24530965 -
Efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia not adequately controlled with current lipid-lowering therapy: design and rationale of the ODYSSEY FH studies
Cardiovasc Drugs Ther, 28 (3), 281-9
DOI 10.1007/s10557-014-6523-z, PubMed 24842558 -
Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: a randomized, double-blind, phase 3 study
Diabetes Care, 38 (3), 355-64
DOI 10.2337/dc13-2762, PubMed 25205142 -
Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010
J Am Heart Assoc, 3 (6), e001236
DOI 10.1161/JAHA.114.001236, PubMed 25468658 -
Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review
Atherosclerosis, 235 (2), 299-309
DOI 10.1016/j.atherosclerosis.2014.05.917, PubMed 24908240 -
Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials
J Am Coll Cardiol, 63 (13), 1278-1288
DOI 10.1016/j.jacc.2014.01.006, PubMed 24509273 -
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
Lancet, 385 (9965), 331-40
DOI 10.1016/S0140-6736(14)61399-4, PubMed 25282519 -
Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study
Lancet Diabetes Endocrinol, 2 (6), 455-63
DOI 10.1016/S2213-8587(14)70006-3, PubMed 24731671 -
Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach
Eur J Hum Genet, 23 (3), 381-7
DOI 10.1038/ejhg.2014.101, PubMed 24916650
Publications 2013
-
[Lipid profile of healthy persons with low-carbohydrate diet]
Tidsskr Nor Laegeforen, 133 (11), 1193-6
DOI 10.4045/tidsskr.12.0034, PubMed 23759780 -
[M. Baumann and colleagues replies]
Tidsskr Nor Laegeforen, 133 (16), 1685-6
DOI 10.4045/tidsskr.13.1023, PubMed 24005696 -
No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy
Scand Cardiovasc J, 47 (2), 80-7
DOI 10.3109/14017431.2012.756119, PubMed 23301875 -
[Treatment with statins]
Tidsskr Nor Laegeforen, 133 (12-13), 1316-9
DOI 10.4045/tidsskr.12.0825, PubMed 23817262 -
Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype
PLoS One, 8 (11), e78241
DOI 10.1371/journal.pone.0078241, PubMed 24244297 -
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial
Circulation, 129 (2), 234-43
DOI 10.1161/CIRCULATIONAHA.113.007012, PubMed 24255061 -
Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia
J Clin Lipidol, 7 (5), 408-13
DOI 10.1016/j.jacl.2013.06.010, PubMed 24079281 -
Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia
Expert Rev Cardiovasc Ther, 11 (8), 1061-6
DOI 10.1586/14779072.2013.814851, PubMed 23984929 -
Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children
J Nutr Sci, 2, e32
DOI 10.1017/jns.2013.27, PubMed 25191582 -
Low level of inflammatory marker in hyperhomocysteinemic patients on statin therapy
Scand J Clin Lab Invest, 74 (1), 1-7
DOI 10.3109/00365513.2013.854926, PubMed 24236948 -
Phytosterol capsules and serum cholesterol in hypercholesterolemia: a randomized controlled trial
Atherosclerosis, 228 (2), 421-5
DOI 10.1016/j.atherosclerosis.2013.03.001, PubMed 23623012 -
UGT1A1*28 is associated with decreased systemic exposure of atorvastatin lactone
Mol Diagn Ther, 17 (4), 233-7
DOI 10.1007/s40291-013-0031-x, PubMed 23580084
Publications 2012
-
Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways
Transl Res, 160 (2), 125-30
DOI 10.1016/j.trsl.2012.01.010, PubMed 22683370 -
Safety of a fixed-dose combination of fenofibrate/pravastatin 160 mg/40 mg in patients with mixed hyperlipidaemia: a pooled analysis from a database of clinical trials
Clin Drug Investig, 32 (4), 281-91
DOI 10.2165/11630820-000000000-00000, PubMed 22350498 -
Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease
Diab Vasc Dis Res, 9 (3), 205-15
DOI 10.1177/1479164111430715, PubMed 22228773 -
Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis
BMC Med, 10, 33
DOI 10.1186/1741-7015-10-33, PubMed 22480336 -
Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia
J Clin Lipidol, 6 (4), 331-9
DOI 10.1016/j.jacl.2012.03.004, PubMed 22836070 -
Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia
J Intern Med, 273 (1), 69-78
DOI 10.1111/j.1365-2796.2012.02584.x, PubMed 22891927 -
Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH
Thromb Res, 131 (2), 178-82
DOI 10.1016/j.thromres.2012.11.008, PubMed 23199546 -
LDL-apheresis affects markers of endothelial function in patients with homozygous familial hypercholesterolemia
Thromb Res, 130 (5), 823-5
DOI 10.1016/j.thromres.2012.06.004, PubMed 22728023 -
Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis
J Clin Lipidol, 7 (2), 109-16
DOI 10.1016/j.jacl.2012.08.001, PubMed 23415429 -
Elevated serum MMP-9/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia: effects of LDL-apheresis
Cytokine, 61 (1), 194-8
DOI 10.1016/j.cyto.2012.09.016, PubMed 23131422 -
Intake of oxidised fish oil does not affect circulating levels of oxidised LDL or inflammatory markers in healthy subjects
Nutr Metab Cardiovasc Dis, 23 (1), e3-4
DOI 10.1016/j.numecd.2012.08.009, PubMed 23146358 -
[Omega-3 fatty acids--both food and medicine]
Tidsskr Nor Laegeforen, 132 (20), 2258
DOI 10.4045/tidsskr.12.1006, PubMed 23736186 -
Substitution of TAG oil with diacylglycerol oil in food items improves the predicted 10 years cardiovascular risk score in healthy, overweight subjects
J Nutr Sci, 1, e17
DOI 10.1017/jns.2012.18, PubMed 25191546
Publications 2011
-
Fixed-dose combination fenofibrate/pravastatin 160/40 mg versus simvastatin 20 mg monotherapy in adults with type 2 diabetes and mixed hyperlipidemia uncontrolled with simvastatin 20 mg: a double-blind, randomized comparative study
Clin Ther, 33 (1), 1-12
DOI 10.1016/j.clinthera.2011.02.006, PubMed 21397769 -
An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia
Pediatr Cardiol, 32 (4), 433-41
DOI 10.1007/s00246-011-9885-z, PubMed 21259004 -
Sun exposure rapidly reduces plasmacytoid dendritic cells and inflammatory dermal dendritic cells in psoriatic skin
Br J Dermatol, 165 (4), 792-801
DOI 10.1111/j.1365-2133.2011.10430.x, PubMed 21623747 -
Paediatric screening for hypercholesterolaemia in Europe
Arch Dis Child, 97 (3), 272-6
DOI 10.1136/archdischild-2011-300081, PubMed 21949015 -
Effect of the fat composition of a single high-fat meal on inflammatory markers in healthy young women
Br J Nutr, 106 (12), 1826-35
DOI 10.1017/S0007114511002510, PubMed 21736782 -
Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors
Inflamm Res, 60 (4), 309-19
DOI 10.1007/s00011-010-0302-5, PubMed 21229287 -
Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia
Atherosclerosis, 216 (2), 426-32
DOI 10.1016/j.atherosclerosis.2011.02.007, PubMed 21376325 -
Pitavastatin: finding its place in therapy
Ther Adv Chronic Dis, 2 (2), 101-17
DOI 10.1177/2040622310389227, PubMed 23251745 -
Oxidised fish oil does not influence established markers of oxidative stress in healthy human subjects: a randomised controlled trial
Br J Nutr, 108 (2), 315-26
DOI 10.1017/S0007114511005484, PubMed 22136711 -
Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy
Mol Diagn Ther, 15 (4), 221-7
DOI 10.1007/BF03256413, PubMed 21815705 -
[Assessment of dietary habits and life style]
Tidsskr Nor Laegeforen, 131 (5), 454
DOI 10.4045/tidsskr.10.0799, PubMed 21383795 -
Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis
Br J Dermatol, 164 (2), 344-55
DOI 10.1111/j.1365-2133.2010.10149.x, PubMed 21271993 -
Pregnancy outcomes in familial hypercholesterolemia: a registry-based study
Circulation, 124 (15), 1606-14
DOI 10.1161/CIRCULATIONAHA.110.990929, PubMed 21911783
Publications 2010
-
Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia
J Am Coll Cardiol, 55 (11), 1121-6
DOI 10.1016/j.jacc.2009.10.042, PubMed 20223367 -
HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study
Scand Cardiovasc J, 44 (4), 197-200
DOI 10.3109/14017431003624123, PubMed 20636227 -
Analysis of LDLR mRNA in patients with familial hypercholesterolemia revealed a novel mutation in intron 14, which activates a cryptic splice site
J Hum Genet, 55 (10), 676-80
DOI 10.1038/jhg.2010.87, PubMed 20703241 -
[Clinical trials--viewpoints from participants]
Tidsskr Nor Laegeforen, 130 (16), 1606-8
DOI 10.4045/tidsskr.09.0030, PubMed 20805857 -
Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor α system and interleukin-10
Atherosclerosis, 214 (1), 163-8
DOI 10.1016/j.atherosclerosis.2010.10.002, PubMed 21040915 -
Pitavastatin: a distinctive lipid-lowering drug
Clin. Lipidol., 5 (3), 309-323
DOI 10.2217/CLP.10.28 -
Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia (vol 210, pg 202, 2010)
Atherosclerosis, 212 (2), 704
DOI 10.1016/j.atherosclerosis.2010.05.023 -
Postradiotherapy plasma lutein, alpha-carotene, and beta-carotene are positively associated with survival in patients with head and neck squamous cell carcinoma
Nutr Cancer, 62 (3), 322-8
DOI 10.1080/01635580903441188, PubMed 20358469 -
Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe)
BMC Med Genet, 11, 144
DOI 10.1186/1471-2350-11-144, PubMed 20939869
Publications 2009
-
[Use of omega-3 fatty acids in the prevention of heart disease]
Tidsskr Nor Laegeforen, 129 (20), 2109-12
DOI 10.4045/tidsskr.08.0447, PubMed 19855449 -
Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia
Acta Obstet Gynecol Scand, 88 (2), 222-6
DOI 10.1080/00016340802503047, PubMed 18972234 -
ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial
JAMA, 301 (11), 1131-9
DOI 10.1001/jama.301.11.1131, PubMed 19293413 -
Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia
Curr Med Res Opin, 25 (11), 2755-64
DOI 10.1185/03007990903290886, PubMed 19785568 -
Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia
Atherosclerosis, 210 (1), 202-8
DOI 10.1016/j.atherosclerosis.2009.12.009, PubMed 20080236 -
Effect of climate therapy at Gran Canaria on vitamin D production, blood glucose and lipids in patients with psoriasis
J Eur Acad Dermatol Venereol, 23 (10), 1133-40
DOI 10.1111/j.1468-3083.2009.03245.x, PubMed 19453805 -
Taspoglutide: a long acting human glucagon-like polypeptide-1 analogue
Expert Opin Investig Drugs, 18 (9), 1405-11
DOI 10.1517/13543780903164205, PubMed 19678802 -
Improved plasma lipids and body weight in overweight/obese patients with type III hyperlipoproteinemia after 4 weeks on a low glycemic diet
Clin Nutr, 28 (2), 213-5
DOI 10.1016/j.clnu.2009.01.018, PubMed 19232793 -
Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins
Br J Nutr, 102 (12), 1783-9
DOI 10.1017/S0007114509991048, PubMed 19682403 -
Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study
Am J Clin Nutr, 90 (4), 960-8
DOI 10.3945/ajcn.2009.27664, PubMed 19710195
Publications 2008
-
Rosuvastatin reduces non-high-density lipoprotein cholesterol and lipoprotein remnants in patients with dysbetalipoproteinemia (Fredrickson type III hyperlipoproteinemia)
J Clin Lipidol, 2 (6), 418-25
DOI 10.1016/j.jacl.2008.10.002, PubMed 21291775 -
[Severe hypertriglyceridemia--an important cause of pancreatitis]
Tidsskr Nor Laegeforen, 128 (9), 1053-6
PubMed 18451886 -
The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects
J Nutr, 138 (11), 2070-5
DOI 10.3945/jn.108.090704, PubMed 18936200 -
[Can cardiovascular events be prevented by raising HDL cholesterol?]
Tidsskr Nor Laegeforen, 128 (13), 1519-23
PubMed 18587459 -
Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening
Community Genet, 11 (1), 26-35
DOI 10.1159/000111637, PubMed 18196915 -
Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects: effect of treatment with B-vitamins
Stroke, 40 (1), 241-7
DOI 10.1161/STROKEAHA.108.522995, PubMed 19008470 -
The real code of leonardo da vinci
Curr Cardiol Rev, 4 (1), 60-2
DOI 10.2174/157340308783565401, PubMed 19924278 -
[The zero vision for arteriosclerotic cardiovascular disease in younger people]
Tidsskr Nor Laegeforen, 128 (10), 1188-90
PubMed 18480870 -
Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia
Scand Cardiovasc J, 42 (4), 279-87
DOI 10.1080/14017430802073073, PubMed 18609053
Publications 2007
-
[Practical advice for registration of clinical trials]
Tidsskr Nor Laegeforen, 127 (12), 1654-6
PubMed 17571106 -
Efficacy and safety of ezetimibe/simvastatin versus simvastatin monotherapy in hypercholesterolemic patients with metabolic syndrome
Metab Syndr Relat Disord, 5 (1), 13-21
DOI 10.1089/met.2006.0033, PubMed 18370810 -
Experiences of guilt and shame in patients with familial hypercholesterolemia: a qualitative interview study
Patient Educ Couns, 69 (1-3), 108-13
DOI 10.1016/j.pec.2007.08.001, PubMed 17889493 -
[Lipid profile in children and adolescents with familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 127 (18), 2363-6
PubMed 17895939 -
Body composition, lipid and lipoprotein levels in childhood-onset systemic lupus erythematosus
Scand J Rheumatol, 36 (1), 40-7
DOI 10.1080/03009740600907881, PubMed 17454934 -
A multi-centre, randomised, double-blind 14-week extension study examining the long-term safety and efficacy profile of the ezetimibe/simvastatin combination tablet
Int J Clin Pract, 61 (9), 1469-80
DOI 10.1111/j.1742-1241.2007.01402.x, PubMed 17655686 -
Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques
Clin Ther, 29 (11), 2419-32
DOI 10.1016/j.clinthera.2007.10.004, PubMed 18158082 -
Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia
J Clin Lipidol, 1 (4), 280-6
DOI 10.1016/j.jacl.2007.07.003, PubMed 21291692 -
The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin
Metabolism, 56 (9), 1285-92
DOI 10.1016/j.metabol.2007.05.003, PubMed 17697874
Publications 2006
-
Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia
Atherosclerosis, 189 (2), 451-7
DOI 10.1016/j.atherosclerosis.2006.01.002, PubMed 16466729 -
Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
Thromb Res, 120 (1), 21-7
DOI 10.1016/j.thromres.2006.07.001, PubMed 16914186 -
Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy
Arterioscler Thromb Vasc Biol, 26 (5), 1094-100
DOI 10.1161/01.ATV.0000204337.81286.1c, PubMed 16424354 -
Perceived vulnerability to heart disease in patients with familial hypercholesterolemia: a qualitative interview study
Ann Fam Med, 4 (3), 198-204
DOI 10.1370/afm.529, PubMed 16735520 -
Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy
Clin Pharmacol Ther, 79 (6), 532-9
DOI 10.1016/j.clpt.2006.02.014, PubMed 16765141 -
Enhanced platelet activation in hyperhomocysteinemic individuals
J Thromb Haemost, 5 (1), 193-5
DOI 10.1111/j.1538-7836.2006.02275.x, PubMed 17059422 -
Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects
Scand J Clin Lab Invest, 66 (1), 45-54
DOI 10.1080/00335510500429821, PubMed 16464786 -
Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects
Stroke, 37 (7), 1731-6
DOI 10.1161/01.STR.0000226465.84561.cb, PubMed 16728689 -
Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis
Curr Med Res Opin, 22 (5), 823-35
DOI 10.1185/030079906X100131, PubMed 16709304 -
Lipid management and cholesterol goal attainment in Norway
Am J Cardiovasc Drugs, 6 (2), 121-8
DOI 10.2165/00129784-200606020-00006, PubMed 16555865 -
Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol efflux
J Nutr, 136 (4), 877-81
DOI 10.1093/jn/136.4.877, PubMed 16549444 -
Increased inflammatory markers in children with familial hypercholesterolaemia
Eur J Clin Invest, 36 (3), 147-52
DOI 10.1111/j.1365-2362.2006.01613.x, PubMed 16506958
Publications 2005
-
Altered composition of HDL3 in FH subjects causing a HDL subfraction with less atheroprotective function
Clin Chim Acta, 359 (1-2), 171-8
DOI 10.1016/j.cccn.2005.03.050, PubMed 15936009 -
Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma
Cancer Lett, 238 (2), 240-7
DOI 10.1016/j.canlet.2005.07.027, PubMed 16157445 -
Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES
Arterioscler Thromb Vasc Biol, 26 (1), 200-5
DOI 10.1161/01.ATV.0000193619.67288.ed, PubMed 16254204 -
Too low blood cholesterol?
Scand J Clin Lab Invest, 65 (1), 1-2
DOI 10.1080/00365510510013488, PubMed 15859021 -
[Does folic acid have effects on other health problems than neural tube defects?]
Tidsskr Nor Laegeforen, 125 (4), 438-41
PubMed 15742017 -
[Effects of public initiatives aimed at reducing neural tube defects with folic acid supplementation]
Tidsskr Nor Laegeforen, 125 (4), 435-7
PubMed 15742016 -
ELOVL3 is an important component for early onset of lipid recruitment in brown adipose tissue
J Biol Chem, 281 (8), 4958-68
DOI 10.1074/jbc.M511588200, PubMed 16326704
Publications 2004
-
Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread
Eur J Clin Nutr, 58 (12), 1612-20
DOI 10.1038/sj.ejcn.1602015, PubMed 15199384 -
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia
Clin Ther, 26 (11), 1758-73
DOI 10.1016/j.clinthera.2004.11.016, PubMed 15639688 -
Psychological factors and cardiovascular disease
J Thromb Haemost, 2 (1), 201-3
DOI 10.1111/j.1538-7836.2004.0562g.x, PubMed 14717990 -
[Hypertriglyceridemia--diagnostics, risk and treatment]
Tidsskr Nor Laegeforen, 124 (21), 2746-9
PubMed 15534665 -
[A family-based strategy for diagnosing familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 124 (9), 1228-9
PubMed 15131703 -
Diagnostic, clinical, and therapeutic aspects of familial hypercholesterolemia in children
Semin Vasc Med, 4 (1), 51-7
DOI 10.1055/s-2004-822986, PubMed 15199433 -
Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans
J Nutr, 134 (3), 562-7
DOI 10.1093/jn/134.3.562, PubMed 14988447 -
Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors
Circulation, 109 (16), 1966-72
DOI 10.1161/01.CIR.0000125700.33637.B1, PubMed 15051633
Publications 2003
-
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups
Clin Cardiol, 26 (11), 509-14
DOI 10.1002/clc.4960261106, PubMed 14640465 -
[Shortcomings and strength of practice guidelines]
Tidsskr Nor Laegeforen, 123 (11), 1566-7
PubMed 12822025 -
CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells
J Thromb Haemost, 1 (2), 257-62
DOI 10.1046/j.1538-7836.2003.00065.x, PubMed 12871498 -
Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects
Eur J Clin Invest, 33 (7), 555-60
DOI 10.1046/j.1365-2362.2003.01189.x, PubMed 12814391 -
Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects
Br J Nutr, 89 (3), 359-63
DOI 10.1079/BJN2002779, PubMed 12628031 -
Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo. Dependency of xanthomas/xanthelasms, smoking and gender
Eur Heart J, 24 (19), 1756-62
DOI 10.1016/s0195-668x(03)00467-6, PubMed 14522571 -
Hyperhomocysteinemic subjects have enhanced expression of lectin-like oxidized LDL receptor-1 in mononuclear cells
J Nutr, 133 (11), 3588-91
DOI 10.1093/jn/133.11.3588, PubMed 14608078 -
Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial
J Pediatr, 143 (1), 74-80
DOI 10.1016/S0022-3476(03)00186-0, PubMed 12915827
Publications 2002
-
Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia
Am J Clin Nutr, 76 (2), 338-44
DOI 10.1093/ajcn/76.2.338, PubMed 12145004 -
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin
Circulation, 106 (17), 2231-7
DOI 10.1161/01.cir.0000035247.42888.82, PubMed 12390953 -
[Guidelines for pharmacological primary prevention of cardiovascular diseases--who should be treated?]
Tidsskr Nor Laegeforen, 122 (23), 2277-81
PubMed 12448268 -
[Which antihypertensive drugs should be used in the primary prevention of cardiovascular disease?]
Tidsskr Nor Laegeforen, 122 (23), 2283-6
PubMed 12448269 -
[Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease?]
Tidsskr Nor Laegeforen, 122 (23), 2287-8
PubMed 12448270 -
Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects
Arterioscler Thromb Vasc Biol, 22 (4), 699-703
DOI 10.1161/01.atv.0000013288.35930.90, PubMed 11950713 -
Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia
Am Heart J, 144 (6), 1044-51
DOI 10.1067/mhj.2002.128049, PubMed 12486429 -
[Müller-Harbitz disease--familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 122 (9), 924-5
PubMed 12082837 -
Familial hypercholesterolemia from children to adults
Cardiovasc Drugs Ther, 16 (4), 289-93
DOI 10.1023/a:1021773724477, PubMed 12652097 -
Reproducibility and validity of a short food questionnaire for the assessment of dietary habits
Nutr Metab Cardiovasc Dis, 12 (2), 60-70
PubMed 12189905
Publications 2001
-
[Transesophageal echocardiography at a small Norwegian district hospital]
Tidsskr Nor Laegeforen, 121 (5), 572-4
PubMed 11301612 -
Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine beta-synthase deficiency: relationship between genotype and phenotype
Am J Med Genet, 100 (3), 204-13
DOI 10.1002/ajmg.1247, PubMed 11343305 -
Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects
Am J Med, 110 (7), 536-42
DOI 10.1016/s0002-9343(01)00696-9, PubMed 11343667 -
Fine mapping of a gene responsible for regulating dietary cholesterol absorption; founder effects underlie cases of phytosterolaemia in multiple communities
Eur J Hum Genet, 9 (5), 375-84
DOI 10.1038/sj.ejhg.5200628, PubMed 11378826 -
[Familial hypercholesterolemia--prognosis and treatment]
Tidsskr Nor Laegeforen, 121 (13), 1635
PubMed 11446054 -
[Genetic screening and treatment in familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 121 (13), 1635-6
PubMed 11446055 -
Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively
Am J Hum Genet, 69 (2), 278-90
DOI 10.1086/321294, PubMed 11452359 -
[Treatment goals for blood lipids in high risk patients of atherosclerotic disease]
Tidsskr Nor Laegeforen, 121 (9), 1059-63
PubMed 11354882 -
Serum cholesterol response to replacing butter with a new trans-free margarine in hypercholesterolemic subjects
Nutr Metab Cardiovasc Dis, 11 (5), 320-6
PubMed 11887429 -
Differences in the conversion of the polyunsaturated fatty acids [1-(14)C]22:4(n-6) and [1-(14)C]22:5(n-3) to [(14)C]22:5(n-6) and [(14)C]22:6(n-3) in isolated rat hepatocytes
Biochim Biophys Acta, 1532 (1-2), 137-47
DOI 10.1016/s1388-1981(01)00127-5, PubMed 11420183
Publications 2000
-
[Cardiologic procedures at a smaller Norwegian hospital--educational potential for assistant residents]
Tidsskr Nor Laegeforen, 120 (18), 2192
PubMed 11006748 -
A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia
Arterioscler Thromb Vasc Biol, 20 (7), 1784-8
DOI 10.1161/01.atv.20.7.1784, PubMed 10894817 -
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia
Nutr Metab Cardiovasc Dis, 10 (5), 253-62
PubMed 11213534 -
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels
Am J Cardiol, 86 (2), 221-3
DOI 10.1016/s0002-9149(00)00942-5, PubMed 10913488 -
Effect of Norwegian fish powder on risk factors for coronary heart disease among hypercholesterolemic individuals
Nutr Metab Cardiovasc Dis, 10 (6), 323-30
PubMed 11302007 -
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group
Clin Cardiol, 23 (1), 39-46
DOI 10.1002/clc.4960230108, PubMed 10680028 -
Cerivastatin gender effect: sub-analyses of results from a multinational, randomised, double-blind study. Cerivastatin Study Group
Curr Med Res Opin, 16 (2), 80-7
PubMed 10893651 -
[The diet of patients with atherosclerotic disease compared with the standard diet in the population]
Tidsskr Nor Laegeforen, 120 (22), 2618-24
PubMed 11077504 -
Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice
Am J Cardiol, 86 (11), 1250-3, A6
DOI 10.1016/s0002-9149(00)01212-1, PubMed 11090801 -
Application of simple lipid treatment goals in patients with atherosclerotic disease
Nutr Metab Cardiovasc Dis, 10 (2), 71-8
PubMed 10919171 -
Does maternal or paternal heredity affect carotid atherosclerosis in children with familial hypercholesterolaemia?
Acta Paediatr, 89 (12), 1490-2
DOI 10.1080/080352500456705, PubMed 11195242
Publications 1999
-
Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I
Am J Cardiol, 83 (10), 1476-7, A7
DOI 10.1016/s0002-9149(99)00153-8, PubMed 10335764 -
Efficacy and safety of 300 micrograms and 400 micrograms cerivastatin once daily in patients with primary hypercholesterolaemia: a multicentre, randomized, double-blind, placebo-controlled study
J Int Med Res, 27 (3), 115-29
DOI 10.1177/030006059902700302, PubMed 10505301 -
Retinoylation of proteins in rat hepatocytes following uptake of chylomicron remnant retinyl ester
Scand J Clin Lab Invest, 59 (5), 315-24
DOI 10.1080/00365519950185508, PubMed 10533843 -
An update on familial hypercholesterolaemia
Ann Med, 31 Suppl 1, 13-8
PubMed 10342495 -
An update on familial hypercholesterolaemia
Ann Med, 31 (sup1), 13-18
DOI 10.1080/07853890.1999.11904394, PubMed 28850282 -
Efficacy and safety of cerivastatin, 0.2 mg and 0.4 mg, in patients with primary hypercholesterolaemia: a multinational, randomised, double-blind study. Cerivastatin Study Group
Curr Med Res Opin, 15 (3), 228-40
DOI 10.1185/03007999909114095, PubMed 10621930 -
Phenotypic consequences of a deletion of exons 2 and 3 of the LDL receptor gene
J Lipid Res, 40 (2), 213-20
PubMed 9925649 -
Mutant transcripts of the LDL receptor gene: mRNA structure and quantity
Hum Mutat, 13 (3), 186-96
DOI 10.1002/(SICI)1098-1004(1999)13:3<186::AID-HUMU2>3.0.CO;2-K, PubMed 10090473 -
Under-reporting of dietary intake by smoking and non-smoking subjects counselled for hypercholesterolaemia
J Intern Med, 245 (4), 337-44
DOI 10.1046/j.1365-2796.1999.00450.x, PubMed 10356595
Publications 1998
-
Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies
Am J Cardiol, 82 (4B), 32J-39J
DOI 10.1016/s0002-9149(98)00435-4, PubMed 9737644 -
Efficacy and six-month safety of simvastatin 80 mg/day: Results from the worldwide simvastatin expanded dose program (WSEDP)
Nutr. Metab. Carbiovasc. Dis., 8 (3), 135-143 -
[Attitude to genetic screening for familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 118 (10), 1578-81
PubMed 9615587 -
Effects of a 9.6-kb deletion of the LDL receptor gene (FH Helsinki) on structure and levels of mRNA
Hum Mutat, 12 (2), 95-102
DOI 10.1002/(SICI)1098-1004(1998)12:2<95::AID-HUMU4>3.0.CO;2-E, PubMed 9671270 -
[Referrals to the Lipid clinic--"appropriate" patients with inadequate anamnesis]
Tidsskr Nor Laegeforen, 118 (5), 749-52
PubMed 9528374 -
Carotid intima-media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects
Eur J Clin Invest, 28 (12), 971-9
DOI 10.1046/j.1365-2362.1998.00399.x, PubMed 9893006 -
The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine
J Pediatr, 132 (2), 365-8
DOI 10.1016/s0022-3476(98)70465-2, PubMed 9506661 -
Expression of retinoic acid receptor and retinoid X receptor subtypes in rat liver cells: implications for retinoid signalling in parenchymal, endothelial, Kupffer and stellate cells
Eur J Cell Biol, 77 (2), 111-6
DOI 10.1016/S0171-9335(98)80078-2, PubMed 9840460 -
Monounsaturated trans fatty acids, elaidic acid and trans-vaccenic acid, metabolism and incorporation in phospholipid molecular species in hepatocytes
Scand J Clin Lab Invest, 58 (8), 635-45
DOI 10.1080/00365519850186067, PubMed 10088200
Publications 1997
-
Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria
Hum Mol Genet, 6 (13), 2213-21
DOI 10.1093/hmg/6.13.2213, PubMed 9361025 -
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I
J Lipid Res, 38 (1), 121-31
PubMed 9034206 -
[Application of gene technology in the diagnosis of familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 117 (5), 678-81
PubMed 9102960 -
[Is there a need for genetic/molecular diagnosis of familial hypercholesterolemia?]
Tidsskr Nor Laegeforen, 117 (5), 681-3
PubMed 9102961 -
Molecular genetics of familial hypercholesterolaemia in Norway
J Intern Med, 241 (3), 185-94
DOI 10.1046/j.1365-2796.1997.78119000.x, PubMed 9104431 -
Storage of vitamin A in extrahepatic stellate cells in normal rats
J Lipid Res, 38 (4), 645-58
PubMed 9144080 -
[What happens with patients after participation in a clinical trial?]
Tidsskr Nor Laegeforen, 117 (28), 4065-9
PubMed 9441437 -
[Drug therapy of hyperlipidemia--unanswered questions]
Tidsskr Nor Laegeforen, 117 (5), 674-7
PubMed 9102959 -
Correlates of plasma total homocysteine in patients with hyperlipidaemia
Eur J Clin Invest, 27 (12), 1025-9
DOI 10.1046/j.1365-2362.1997.2260772.x, PubMed 9466131 -
[Diagnosis and treatment of severe hyperlipidemia]
Tidsskr Nor Laegeforen, 117 (29), 4241-4
PubMed 9441469 -
Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia
Circulation, 96 (6), 1803-8
DOI 10.1161/01.cir.96.6.1803, PubMed 9323065 -
Flow cytometric measurement of low density lipoprotein receptor activity validated by DNA analysis in diagnosing heterozygous familial hypercholesterolemia
Cytometry, 30 (5), 264-8
PubMed 9383100
Publications 1996
-
Two novel missense mutations in the LDL receptor gene causing familial hypercholesterolemia
Clin Genet, 49 (2), 85-7
DOI 10.1111/j.1399-0004.1996.tb04333.x, PubMed 8740918 -
Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein
J Lipid Res, 37 (7), 1591-600
PubMed 8827529 -
Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia (vol 95, pg 671, 1995)
Hum. Genet., 97 (2), 268
DOI 10.1007/BF02265281 -
Phytosterolaemia in a Norwegian family: diagnosis and characterization of the first Scandinavian case
Scand J Clin Lab Invest, 56 (3), 229-40
DOI 10.3109/00365519609088612, PubMed 8761527 -
The C-terminal RNLL sequence of the plasma retinol-binding protein is not responsible for its intracellular retention
Biochem Biophys Res Commun, 221 (2), 374-9
DOI 10.1006/bbrc.1996.0603, PubMed 8619863 -
Effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women
Eur J Clin Invest, 26 (12), 1062-8
DOI 10.1046/j.1365-2362.1996.390593.x, PubMed 9013080 -
Simvastatin-fluvastatin comparative study - Reply
Clin. Drug Invest., 11 (6), 363-364 -
Simvastatin-fluvastatin comparative study - Continued - Reply
Clin. Drug Invest., 12 (1), 57 -
Results of intensive long-term treatment of familial hypercholesterolemia
Am J Cardiol, 78 (12), 1369-74
DOI 10.1016/s0002-9149(96)00649-2, PubMed 8970408 -
A common missense mutation (C210G) in the LDL receptor gene among Norwegian familial hypercholesterolemia subjects
Hum Mutat, 7 (1), 70-1
DOI 10.1002/(SICI)1098-1004(1996)7:1<70::AID-HUMU12>3.0.CO;2-P, PubMed 8664907 -
Familial hypercholesterolaemia: a pilot study of parents' and children's concerns
Acta Paediatr, 85 (11), 1307-13
DOI 10.1111/j.1651-2227.1996.tb13916.x, PubMed 8955457 -
Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects
Arterioscler Thromb Vasc Biol, 16 (8), 984-91
DOI 10.1161/01.atv.16.8.984, PubMed 8696963 -
Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia
J Pediatr, 129 (1), 42-9
DOI 10.1016/s0022-3476(96)70188-9, PubMed 8757561 -
Colestipol tablets in adolescents with familial hypercholesterolaemia
Acta Paediatr, 85 (9), 1080-2
DOI 10.1111/j.1651-2227.1996.tb14221.x, PubMed 8888922 -
Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives
Pediatr Res, 40 (1), 47-52
DOI 10.1203/00006450-199607000-00009, PubMed 8798245 -
Low dose colestipol in adolescents with familial hypercholesterolaemia
Arch Dis Child, 74 (2), 157-60
DOI 10.1136/adc.74.2.157, PubMed 8660081 -
The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein (a) levels in familial hypercholesterolemia
Metabolism, 45 (11), 1415-21
DOI 10.1016/s0026-0495(96)90124-9, PubMed 8931648
Publications 1995
-
Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein composition
Metabolism, 44 (11), 1447-54
DOI 10.1016/0026-0495(95)90145-0, PubMed 7476333 -
Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group
Am J Cardiol, 76 (2), 65A-70A
DOI 10.1016/s0002-9149(05)80021-9, PubMed 7604802 -
CHANGES IN PLASMA APOLIPOPROTEIN B-CONTAINING LIPOPARTICLE LEVELS FOLLOWING THERAPY WITH FLUVASTATIN AND CHOLESTYRAMINE
Am. J. Cardiol., 76 (2), A65-A70 -
[Diet and lipid status in pregnant women]
Tidsskr Nor Laegeforen, 115 (11), 1358-60
PubMed 7770831 -
Identification of the apo B-3500 mutation in the Norwegian population
Scand J Clin Lab Invest, 55 (3), 217-21
DOI 10.3109/00365519509089616, PubMed 7638555 -
Two novel point mutations in the EGF precursor homology domain of the LDL receptor gene causing familial hypercholesterolemia
Hum Genet, 96 (2), 241-2
DOI 10.1007/BF00207391, PubMed 7635482 -
Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia
Hum Genet, 95 (6), 671-6
DOI 10.1007/BF00209485, PubMed 7789953 -
Standardization of a flow cytometric method for measurement of low-density lipoprotein receptor activity on blood mononuclear cells
Cytometry, 20 (4), 290-5
DOI 10.1002/cyto.990200404, PubMed 7587716 -
No effect of beta-carotene supplementation on the susceptibility of low density lipoprotein to in vitro oxidation among hypercholesterolaemic, postmenopausal women
Scand J Clin Lab Invest, 55 (6), 477-85
DOI 10.3109/00365519509075385, PubMed 8571077 -
FIRST ANNUAL COPENHAGEN ATHEROSCLEROSIS CONFERENCE
Arterioscl. Thromb. Vasc. Biol., 15 (10), 1787-1790 -
[Treatment of hyperlipidemia. Guidelines for treatment of hyperlipidemia for secondary prevention of ischemic heart disease]
Tidsskr Nor Laegeforen, 115 (29), 3629-31
PubMed 8539720 -
Erratum to Double-blind comparison of the efficacy and tolerability of simvastatin and fluvastatin in patients with primary hypercholesterolaemia
Clin Drug Investig, 10 (6), 343
DOI 10.1007/BF03259374, PubMed 27519335 -
Double-Blind Comparison of the Efficacy and Tolerability of Simvastatin and Fluvastatin in Patients with Primary Hypercholesterolaemia
Clin Drug Investig, 10 (3), 127-38
DOI 10.2165/00044011-199510030-00001, PubMed 27519196 -
[Familial hypercholesterolemia in children. A management program. Procedures for diagnosis and treatment in our pediatric departments]
Tidsskr Nor Laegeforen, 115 (28), 3514
PubMed 7491607 -
The detection and management of dyslipidaemia in children and adolescents
Acta Paediatr, 84 (11), 1213-5
PubMed 8580613 -
[Diagnosis and treatment of familial hypercholesterolemia in children and adolescents]
Tidsskr Nor Laegeforen, 115 (28), 3499-503
PubMed 7491603 -
[A rapid analysis of the lipid profile. A comparative study of different analytical methods for determination of blood lipids]
Tidsskr Nor Laegeforen, 115 (28), 3487-9
PubMed 7491599 -
Effect of large-volume liposuction on sex hormones and glucose- and lipid metabolism in females
Aesthetic Plast Surg, 19 (2), 131-5
DOI 10.1007/BF00450248, PubMed 7598023 -
A novel variant of lysosomal acid lipase (Leu336-->Pro) associated with acid lipase deficiency and cholesterol ester storage disease
Arterioscler Thromb Vasc Biol, 15 (6), 773-8
DOI 10.1161/01.atv.15.6.773, PubMed 7773732 -
[Antioxidants and cardiovascular disorders--epidemiologic aspects. Should high risk patients receive supplementation?]
Tidsskr Nor Laegeforen, 115 (2), 227-9
PubMed 7855818 -
EFFECTIVENESS OF COLESTIPOL TABLETS VS GRANULES IN PATIENTS WITH MODERATE TO SEVERE HYPERCHOLESTEROLEMIA
Clin. Drug Invest., 10 (5), 257-263
DOI 10.2165/00044011-199510050-00002 -
PHYSICAL-FITNESS AND FIBRINOGEN LEVELS AMONG HYPERCHOLESTEROLEMIC POSTMENOPAUSAL WOMEN
Nutr. Metab. Carbiovasc. Dis., 5 (2), 93-97 -
Is dietary intervention effective in post-transplant hyperlipidaemia?
Nephrol Dial Transplant, 10 (1), 82-5
PubMed 7724035 -
Determinants of lipid levels among children with heterozygous familial hypercholesterolemia in Norway
Arterioscler Thromb Vasc Biol, 15 (8), 1009-14
DOI 10.1161/01.atv.15.8.1009, PubMed 7627689 -
Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women
J Intern Med, 238 (1), 39-47
DOI 10.1111/j.1365-2796.1995.tb00897.x, PubMed 7608645 -
Screening for familial hypercholesterolaemia in relatives
Lancet, 346 (8987), 1438
DOI 10.1016/s0140-6736(95)92461-2, PubMed 7475864
Publications 1994
-
[Diet therapy of hypercholesterolemia. Can the diet of persons who already follow a cholesterol-lowering diet be further improved by guidelines given by a clinical nutritionist?]
Tidsskr Nor Laegeforen, 114 (18), 2106-8
PubMed 7992266 -
[Iron status in postmenopausal women]
Tidsskr Nor Laegeforen, 114 (4), 436-8
PubMed 8009479 -
Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine
Eur J Clin Pharmacol, 46 (5), 445-9
DOI 10.1007/BF00191909, PubMed 7957541 -
Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects
Atherosclerosis, 111 (2), 175-82
DOI 10.1016/0021-9150(94)90091-4, PubMed 7718019 -
Modification of low density lipoprotein in relation to intake of fatty acids and antioxidants
World Rev Nutr Diet, 75, 144-8
DOI 10.1159/000423570, PubMed 7871817 -
Familial hypercholesterolaemia caused by a non-sense mutation in codon 329 of the LDL receptor gene
Scand J Clin Lab Invest, 54 (8), 605-9
DOI 10.3109/00365519409087539, PubMed 7709162 -
[A comparison between lovastatin and pravastatin--effects on lipids, sleep and quality of life in primary hyperlipidemia]
Tidsskr Nor Laegeforen, 114 (19), 2262-4
PubMed 7992293 -
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia
Eur J Clin Pharmacol, 46 (5), 405-10
DOI 10.1007/BF00191901, PubMed 7957533 -
RESPONSIVENESS TO DIETARY INDULGENCE AMONG PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
Nutr. Metab. Carbiovasc. Dis., 4 (3), 159-162
Publications 1993
-
A MULTICENTER COMPARATIVE TRIAL OF LOVASTATIN AND PRAVASTATIN IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
Am. J. Cardiol., 71 (10), 810-815 -
[Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III]
Tidsskr Nor Laegeforen, 113 (7), 853-6
PubMed 8480294 -
Evaluation of running conditions for SSCP analysis: application of SSCP for detection of point mutations in the LDL receptor gene
PCR Methods Appl, 3 (3), 159-62
DOI 10.1101/gr.3.3.159, PubMed 8118396 -
Screening for point mutations in exon 10 of the low density lipoprotein receptor gene by analysis of single-strand conformation polymorphisms: detection of a nonsense mutation-FH469-->Stop
Hum Genet, 92 (1), 6-10
DOI 10.1007/BF00216137, PubMed 8103503 -
Haplotype analysis at the low density lipoprotein receptor locus in normal and familial hypercholesterolemia Norwegian subjects
Clin Genet, 44 (4), 214-20
DOI 10.1111/j.1399-0004.1993.tb03883.x, PubMed 7903228 -
MSPL RFLP IN EXON 18 OF THE LDL RECEPTOR GENE DETECTABLE BY PCR
Clin. Genet., 44 (2), 111 -
Short report on DNA marker at candidate locus
Clin Genet, 44 (2), 111
PubMed 8275559 -
Effectiveness of low-dose lovastatin combined with low-dose colestipol in moderate to severe primary hypercholesterolaemia
Scand J Clin Lab Invest, 53 (5), 457-63
DOI 10.1080/00365519309092540, PubMed 8210967
Publications 1992
-
Effects of dietary purified eicosapentaenoic acid (20:5 (n-3)) and docosahexaenoic acid (22:6(n-3)) on fatty acid desaturation and oxidation in isolated rat liver cells
Biochim Biophys Acta, 1125 (1), 35-43
DOI 10.1016/0005-2760(92)90152-l, PubMed 1533162 -
A new polymorphism in exon 11 of the LDL receptor gene in healthy people and in familial hypercholesterolemia subjects
Clin Genet, 42 (5), 224-8
DOI 10.1111/j.1399-0004.1992.tb03245.x, PubMed 1486698 -
[Triglycerides, HDL and coronary disease. Consensus conference: National Institutes of Health 1992]
Tidsskr Nor Laegeforen, 112 (21), 2768-71
PubMed 1412312 -
[Lovastatin in primary hypercholesterolemia. A Norwegian multicenter study]
Tidsskr Nor Laegeforen, 112 (29), 3665-9
PubMed 1471127 -
[Quality assurance in clinical trials. Problems related to patient information]
Tidsskr Nor Laegeforen, 112 (25), 3204-7
PubMed 1462295 -
Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia
Eur J Clin Pharmacol, 42 (1), 61-4
DOI 10.1007/BF00314921, PubMed 1541317 -
A 9.6 kilobase deletion in the low density lipoprotein receptor gene in Norwegian familial hypercholesterolemia subjects
Clin Genet, 42 (6), 288-95
DOI 10.1111/j.1399-0004.1992.tb03258.x, PubMed 1362925 -
Uptake of chylomicron remnant retinyl esters in human leukocytes in vivo
Eur J Clin Invest, 22 (4), 229-34
DOI 10.1111/j.1365-2362.1992.tb01456.x, PubMed 1499639 -
[Familial hypercholesterolemia--intensive diet therapy combined with drug therapy]
Tidsskr Nor Laegeforen, 112 (20), 2642-6
PubMed 1412289
Publications 1991
-
[Treatment of hypercholesterolemia in adults. A treatment program 1991]
Tidsskr Nor Laegeforen, 111 (28), 3407-11
PubMed 1792668 -
Dietary n-6 fatty acids inhibit the incorporation of dietary n-3 fatty acids in thrombocyte and serum phospholipids in humans: a controlled dietetic study
Scand J Clin Lab Invest, 51 (3), 255-63
DOI 10.3109/00365519109091612, PubMed 1909049 -
Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system
Arterioscler Thromb, 11 (1), 138-45
DOI 10.1161/01.atv.11.1.138, PubMed 1987991 -
[Dietary supplementation in the treatment of hyperlipidemia]
Tidsskr Nor Laegeforen, 111 (28), 3398-400
PubMed 1665257
Publications 1990
-
[Identification of syndromes using a combined computer and video program]
Tidsskr Nor Laegeforen, 110 (9), 1085-7
PubMed 2184540 -
[Are prosecuted parents allowed the benefit of the doubt in cases of child abuse?]
Tidsskr Nor Laegeforen, 110 (5), 627-8
PubMed 2309218
Publications 1989
-
[Marketing of Carduran]
Tidsskr Nor Laegeforen, 109 (17-18), 1920-1
PubMed 2526393 -
[Drug therapy of hypercholesterolemia. Treatment of hypercholesterolemia in adults--a Norwegian therapeutic program 1988]
Tidsskr Nor Laegeforen, 109 (7-8), 850-2
PubMed 2705170 -
Familial hypercholesterolemia. 50 years of research
Arteriosclerosis, 9 (1 Suppl), I1-2
PubMed 2643426
Publications 1988
-
Effects of adrenaline on excitation-induced stimulation of the sodium-potassium pump in rat skeletal muscle
Acta Physiol Scand, 134 (2), 189-98
DOI 10.1111/j.1748-1716.1988.tb08479.x, PubMed 2852445 -
[Fraser's syndrome--cryptophthalmia]
Tidsskr Nor Laegeforen, 108 (25), 1998-9
PubMed 3144053 -
Computed tomography of a tuberculous paravertebral abscess
Z Kinderchir, 43 (6), 430-2
DOI 10.1055/s-2008-1044106, PubMed 3239258
Publications 1987
-
[Treatment of familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 107 (32), 2836-8, 2840
PubMed 3321550 -
[Cardiovascular diseases: we start with children]
Nord Med, 102 (10), 265-6
PubMed 3697042
Publications 1983
-
Autosomal dominant partial lipodystrophy associated with Rieger anomaly, short stature, and insulinopenic diabetes
Am J Med Genet, 15 (1), 29-38
DOI 10.1002/ajmg.1320150104, PubMed 6407320
Publications 1981
-
Intracellular degradation of 125I-labelled asialo-glycoproteins in rat hepatocytes: effect of leupeptin on subcellular distribution of asialo-fetuin
Int J Biochem, 13 (3), 253-9
DOI 10.1016/0020-711x(81)90076-8, PubMed 6163669 -
The binding of high density lipoproteins to isolated rat hepatocytes
Scand J Clin Lab Invest, 41 (1), 63-73
DOI 10.3109/00365518109092016, PubMed 7256194 -
Binding, uptake, and degradation of 125I-labelled high-density lipoproteins in isolated non-parenchymal rat liver cells
Scand J Gastroenterol, 16 (1), 71-80
PubMed 7233082
Publications 1980
-
The intracellular distribution of high density lipoproteins taken up by isolated rat hepatocytes
Biochim Biophys Acta, 620 (1), 120-32
DOI 10.1016/0005-2760(80)90191-5, PubMed 6251895 -
Fluid endocytosis in isolated rat parenchymal and non-parenchymal liver cells
Exp Cell Res, 126 (1), 109-19
DOI 10.1016/0014-4827(80)90475-9, PubMed 7188905 -
The effect of ammonia, chloroquine, leupeptin, colchicine and cytochalasin B on degradation of high density lipoproteins in isolated rat hepatocytes
Exp Cell Res, 130 (1), 127-35
DOI 10.1016/0014-4827(80)90049-x, PubMed 7192635 -
Catabolism of (125-I)low density lipoproteins in isolated rat liver cells
Biochem Biophys Res Commun, 97 (1), 192-9
DOI 10.1016/s0006-291x(80)80153-7, PubMed 7458932
Publications 1979
-
Uptake and degradation of 125I-labelled high density lipoproteins in rat liver cells in vivo and in vitro
Biochim Biophys Acta, 574 (3), 521-36
DOI 10.1016/0005-2760(79)90248-0, PubMed 226159
Publications 1977
-
A heritable syndrome of craniosynostosis, short thin hair, dental abnormalities, and short limbs: cranioectodermal dysplasia
J Pediatr, 90 (1), 55-61
DOI 10.1016/s0022-3476(77)80764-6, PubMed 830894 -
Hyperlipidemia: clinical clues in the first two decades of life
Johns Hopkins Med J, 140 (4), 171-6
PubMed 850334 -
[Hyperlipemia in children]
Tidsskr Nor Laegeforen, 97 (2), 67-73
PubMed 835105 -
Prophylactiv use of propranolol in the Marfan syndrome to prevent aortic dissection
Birth Defects Orig Artic Ser, 13 (3C), 163-9
PubMed 19114
Publications 1976
-
Circulating dopamine-beta-hydroxylase (DbetaH) and catecholamines in a paediatric phaeochromocytoma
Clin Exp Pharmacol Physiol, 3 (5), 487-91
DOI 10.1111/j.1440-1681.1976.tb00627.x, PubMed 975634 -
Letter: Usefulness of the xylose test for coeliac disease
Arch Dis Child, 51 (5), 400-1
DOI 10.1136/adc.51.5.400, PubMed 938086 -
Serum beta-lipoprotein subfractions in polyacrylamide gel electrophoresis associated with coronary heart disease
Scand J Clin Lab Invest, 36 (1), 75-9
DOI 10.1080/00365517609068021, PubMed 176718 -
Neonatal osteomyelitis caused by group B streptococci
Scand J Infect Dis, 8 (3), 219-21
DOI 10.3109/inf.1976.8.issue-3.20, PubMed 788147
Publications 1975
-
[Finnish families in the town of Sør-Varanger. II. A study of blood pressure, height, weight, cholesterol, triglycerides and lipoprotein electrophoresis among Finnish men - combined effects of a change in diet]
Sykepleien, 62 (16), 728-35
PubMed 1043245 -
Letter: L.D.L. and total cholesterol in cord-blood screening for familial hypercholesterolaemia
Lancet, 2 (7935), 615-6
DOI 10.1016/s0140-6736(75)90216-0, PubMed 51449 -
[Encephalitis associated with mycoplasma pneumoniae infection in children]
Tidsskr Nor Laegeforen, 95 (12), 756-8,779
PubMed 1145545 -
Neonatal screening for hyperlipidaemia
Postgrad Med J, 51 (8), suppl 88-92
PubMed 215987 -
Neonatal screening for hyperlipidaemia
Postgrad Med J, 51 (8), 88-92
PubMed 1221382
Publications 1974
-
[Finnish descendants in the municipality of Sor-Varanger--II. An investigation of blood pressure, height, weight, cholesterol, triglycerides and lipoproteins among Finnish descendant men--and the effect of a diet change]
Tidsskr Nor Laegeforen, 94 (26), 1565-72
PubMed 4422489 -
[Routine methods for fibrinogen determination]
Tidsskr Nor Laegeforen, 94 (30), 2085-7
PubMed 4214421 -
[The D-xylose-tolerance test as screeningtest for malabsorption diseases in children]
Tidsskr Nor Laegeforen, 94 (18), 1192-5
PubMed 4839995
Publications 1973
-
[D-xylose tolerance in malabsorption. Method of determination of D-xylose in serum and urine]
Tidsskr Nor Laegeforen, 93 (28), 2103-5
PubMed 4773981